| Literature DB >> 28133615 |
Demetra-Gabriela Socolov1, Magdalena Iorga2, Alexandru Carauleanu1, Ciprian Ilea1, Iolanda Blidaru1, Lucian Boiculese3, Razvan-Vladimir Socolov4.
Abstract
Aim. To determine pregnancy and delivery outcomes among teenagers. Materials and Methods. An 8-year retrospective comparative hospital-based cohort study is analysing singleton pregnancy comorbidities and delivery parameters of a teenage group under the age of 20 compared with a young adult group 20-24 years of age in a university hospital. Results. Teenage is a risk factor for preterm birth <37 weeks (1.21 [1.08-1.35]), foetal growth restriction (1.34 [1.21-1.48]), episiotomy (1.27 [1.21-1.34]), uterine revision (1.15 [1.06-1.25]), APGAR <7 at 1 min (2.42 [1.21-1.67]), cephalopelvic disproportion (1.26 [1.07-1.48]), and postpartum haemorrhage (1.42 [1.25-1.62]); however, caesarean delivery occurs less frequently in teenagers than in adults (0.75 [0.70-0.80]). The following comorbidities are risk factors for teenage pregnancy (risk ratio [CI 95%]): anaemia (1.13 [1.10-1.17]), low urinary tract infection (1.10 [1.03-1.18]), pediculosis (2.42 [1.90-3.00]), anogenital condyloma (1.50 [1.04-2.17]), and trichomoniasis (1.74 [1.12-2.68]). The risks for hepatitis B and hepatitis C, premature rupture of membranes, and placenta praevia were lower compared with those in the young adult group, respectively, 0.43 (0.26-0.71), 0.90 (0.85-0.96), and 0.29 (0.20-0.41), while the risk for gestational diabetes and preeclampsia were the same in both groups. Conclusion. Considering the high risks for teenage pregnancy, this information should be provided to pregnant adolescent women and their caregivers.Entities:
Mesh:
Year: 2017 PMID: 28133615 PMCID: PMC5241487 DOI: 10.1155/2017/9205016
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Maternal age distribution in the entire cohort of singleton adolescent women.
| Age | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| Number of cases | 4 | 9 | 37 | 145 | 371 | 710 | 1165 | 1450 |
Risk of pregnancy comorbidities among teenagers in comparison with young adults (20–24 years of age).
| Comorbidity; | Age 12–17 | Age 18-19 | Age 12–19 | Age 20–24 |
|---|---|---|---|---|
| Age of the study group (mean ± SD) | 16.35 ± 0.88 | 18.55 ± 0.497 | 17.81 ± 1.25 | 22.18 ± 1.42 |
| Chronic/gestational hypertension | 54 (4.23%) | 93 (3.55%) | 147 (3.77%) | 375 (3.95%) |
| Preeclampsia | 5 (0.39%) | 7 (0.54%) | 12 (0.30%) | 22 (0.23%) |
| Foetal anomalies | 0 | 6 (0.22%) | 6 (0.15%) | 28 (0.29%) |
| Anaemia | 873 (68.41%) | 1722 (65.85%) | 2595 (66.69%) | 5557 (58.62%) |
| Diabetes (gestational, pregestational) | 1 (0.07%) | 3 (0.11%) | 4 (0.10%) | 33 (0.34%) |
| Obesity | 59 (0.39%) | 18 (0.68%) | 23 (0.59%) | 94 (0.99%) |
| Low urinary tract infection | 344 (26.95%) | 637 (24.35%) | 981 (25.21%) | 2159 (22.77%) |
| High urinary tract infection | 1 (0.07%) | 4 (0.15%) | 5 (0.12%) | 31 (0.32%) |
| Pediculosis | 78 (6.11%) | 75 (2.86%) | 153 (3.93%) | 154 (1.62%) |
| Anogenital condyloma | 24 (1.88%) | 21 (0.80%) | 45 (1.15%) | 74 (0.78%) |
| Lues/syphilis | 7 (0.54%) | 16 (0.61%) | 23 (0.59%) | 34 (0.35%) |
| Trichomonas | 12 (0.94%) | 23 (0.87%) | 35 (0.89%) | 49 (0.51%) |
|
| 192 (15.04%) | 311 (11.89%) | 503 (12.92%) | 1133 (11.95%) |
|
| 54 (4.23%) | 107 (4.09%) | 161 (4.13%) | 467 (4.92%) |
|
| 89 (6.97%) | 139 (5.31%) | 228 (5.85%) | 671 (7.07%) |
|
| 23 (1.80%) | 18 (0.68%) | 41 (1.05%) | 102 (1.07%) |
|
| 18 (1.41%) | 19 (0.72%) | 37 (0.95%) | 74 (0.78%) |
|
| 0 | 2 (0.07%) | 2 (0.05%) | 6 (0.06%) |
| HIV infection | 2 (0.15%) | 4 (0.15%) | 6 (0.15%) | 20 (0.21%) |
| Hepatitis B and hepatitis C | 3 (0.23%) | 15 (0.57%) | 18 (0.46%) | 101 (1.06%) |
| Premature rupture of membranes | 261 (20.45%) | 702 (26.84%) | 963 (24.74%) | 2581 (27.22%) |
| Chorioamnionitis | 16 (1.25%) | 73 (2.79%) | 89 (2.28%) | 249 (2.62%) |
| Placenta praevia | 9 (0.70%) | 27 (1.03%) | 36 (0.92%) | 297 (3.13%) |
Delivery characteristics and outcome among teenagers in comparison with young adults (20–24 years of age).
| Delivery characteristics | Age 12–17 | Age 18-19 | Age ≤ 19 | Age 20–24 |
|---|---|---|---|---|
| Gestational age (M ± SD) | 38.13 ± 2.10 | 38.39 ± 1.90 | 38.31 ± 1.97 | 38.42 ± 1.81 |
| Preterm birth | ||||
| <37 wa | 170 (13.32%) | 244 (9.33%) | 414 (10.63%) | 842 (8.88%) |
| <34 wa | 51 (3.99%) | 70 (2.67%) | 121 (3.10%) | 255 (2.69%) |
| <28 wa | 5 (0.39%) | 10 (0.38%) | 15 (0.38%) | 43 (0.45%) |
| Birth weight at delivery (gr) | 3010 | 3136 | 3096 | 3227.08 ± 539.11 |
| Very low birth weight <1500 g | 23 (1.80%) | 32 (1.22%) | 55 (1.41%) | 117 (1.23%) |
| Low birth weight <2500 g | 161 (12.61%) | 222 (8.48%) | 383 (9.84%) | 1043 (11.00%) |
| FGR (foetal growth restriction) | 184 (14.42%) | 352 (13.46%) | 536 (13.77%) | 986 (10.40%) |
| Caesarean section | 292 (22.88%) | 604 (23.09%) | 896 (23.02%) | 2905 (30.64%) |
| Episiotomy | 466 (36.52%) | 920 (35.18%) | 1386 (35.62%) | 2382 (25.12%) |
| Perineal rupture of 1st, 2nd degree | 85 (6.66%) | 258 (9.86%) | 343 (8.81%) | 1232 (12.99%) |
| Perineal rupture of 3rd, 4th degree | 5 (0.39%) | 6 (0.22%) | 11 (0.28%) | 34 (0.35%) |
| Cervical laceration | 45 (3.52%) | 74 (2.82%) | 119 (3.05%) | 220 (2.32%) |
| Instrumental delivery (Forceps and Vidextractor) | 3 (0.23%) | 19 (0.72%) | 22 (0.56%) | 41 (0.43%) |
| Cephalopelvic disproportion | 86 (6.73%) | 120 (4.58%) | 206 (5.29%) | 397 (4.18%) |
| Dystocic presentations, humeral | 7 (0.54%) | 7 (0.26%) | 14 (0.35%) | 24 (0.25%) |
| Dystocic presentations | 43 (3.36%) | 102 (3.90%) | 145 (3.72%) | 430 (4.53%) |
| Postpartum haemorrhage | 125 (9.79%) | 214 (8.18%) | 339 (8.71%) | 579 (6.10%) |
| Instrumental/manual uterine revision | 243 (19.4%) | 406 (15.52%) | 649 (16.67%) | 8247 (88.90%) |
| Apgar <7 at 1 min | 92 (7.21%) | 131 (5.00%) | 223 (5.73%) | 386 (4.07%) |
| Apgar <7 at 5 min | 30 (2.35%) | 31 (1.18%) | 61 (1.56%) | 108 (1.13%) |
| Hospitalisation (number of days) (M ± SD ) | 5.97 ± 3.96 | 6.68 ± 3.84 | .44 ± 3.89 | 6.59 ± 4.23 |
Notes: wa = weeks of amenorrhea.